Pantalis - D

Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Pantalis 40 Injection VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC CEFOTEM-1.5 INJ CEFTRALIS INJ
VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC VOCLAV 625 Azivoc-500 tab Rbvoc-DSR Rabeprazole

Explore Our Prodcuts

Pantalis-D provides effective and long-lasting relief for patients suffering from acid reflux, GERD (Gastroesophageal Reflux Disease), dyspepsia, and upper gastrointestinal disorders associated with nausea and bloating. Formulated with a powerful combination of Pantoprazole (40 mg) and Domperidone (10 mg), it works by reducing excess stomach acid while enhancing gastric motility and preventing reflux-related symptoms.

It is highly effective in the management of reflux esophagitis, functional dyspepsia, gastritis, and nausea-vomiting linked with acid-related conditions. By combining acid suppression with prokinetic action, Pantalis-D not only controls symptoms but also improves digestive comfort and patient quality of life.

Backed by clinical data, Pantalis-D shows a high success rate in relieving GERD symptoms, reducing regurgitation, and preventing recurrence, ensuring rapid recovery and sustained relief.

Research & Clinical Data for Pantalis-D

Indications Supported by Evidence

  • GERD & Acid Reflux with Nausea: Demonstrated dual benefit in acid suppression and relief from regurgitation and vomiting.
  • Functional Dyspepsia & Gastritis: Shown to improve gastric emptying, reduce bloating, and relieve upper abdominal discomfort.
  • Reflux Esophagitis: Proven efficacy in mucosal healing and long-term symptom management.